$4.340
Price Predictions
Open in app to unlock longer-horizon forecasts.
PBM Prediction & Forecast by Similar Chart Analysis
Alphio's PBM stock price prediction model matches the current Psyence Biomedical Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.40 (+0.79%). The 1-week path is $4.38 (+0.17%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Psyence Biomedical Ltd Stock?
Psyence Biomedical Ltd is currently priced at $4.57, which is relatively stable but shows a 2.41% increase recently. However, the company reported a significant net loss of $753,254 in Q2 2026, indicating financial challenges. The RSI is at 58.53, suggesting the stock is neither overbought nor oversold, but the forward P/E ratio is at 0, indicating uncertainty in future earnings. While there are positive catalysts such as U.S. government support for ibogaine development, the financial performance raises concerns, making it a hold rather than a buy.
Psyence Biomedical Ltd (PBM) last closed at $4.37, gaining +0.69%
These facts feed the 1-day and 1-week PBM price prediction above.
Forecast Drivers
Psyence Biomedical Ltd (PBM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PBM, ranked by similarity.
Seasonality analysis for PBM
Historically the probability of a positive September return for PBM is 0.00%. January offers the highest probability of a positive month at 18.03%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PBM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $4.52 | $5.16 | $5.95 | +18.09% |
| Oct 2026 | $4.71 | $5.18 | $5.49 | +18.56% |
| Nov 2026 | $5.16 | $5.88 | $6.41 | +34.50% |
| Dec 2026 | $4.35 | $4.52 | $4.72 | +3.39% |
In 2026, Psyence Biomedical Ltd (PBM) is projected to range from $4.35 to $6.41.
Psyence Biomedical Ltd 2026 monthly forecast
In Sep 2026, Psyence Biomedical Ltd is projected to average $5.16, with a low of $4.52 and high of $5.95.
In Oct 2026, Psyence Biomedical Ltd is projected to average $5.18, with a low of $4.71 and high of $5.49.
In Nov 2026, Psyence Biomedical Ltd is projected to average $5.88, with a low of $5.16 and high of $6.41.
In Dec 2026, Psyence Biomedical Ltd is projected to average $4.52, with a low of $4.35 and high of $4.72.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.